136 related articles for article (PubMed ID: 11984571)
1. Gene therapy in recovery phase.
Ready T
Nat Med; 2002 May; 8(5):429-30. PubMed ID: 11984571
[No Abstract] [Full Text] [Related]
2. Gene therapy of severe combined immunodeficiencies.
Fischer A; Hacein-Bey S; Cavazzana-Calvo M
Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
[TBL] [Abstract][Full Text] [Related]
3. Looking into the safety of AAV vectors.
Kay MA; Nakai H
Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
[No Abstract] [Full Text] [Related]
4. Future tense for in utero gene therapy.
Fox JL
Nat Biotechnol; 1998 Nov; 16(11):1002-3. PubMed ID: 9831019
[No Abstract] [Full Text] [Related]
5. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
Gaspar HB; Howe S; Thrasher AJ
Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy for primary immunodeficiency diseases].
Ariga T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():641-5. PubMed ID: 16416867
[No Abstract] [Full Text] [Related]
8. Gene therapy rising?
Hoag H
Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
[No Abstract] [Full Text] [Related]
9. [It is no more about cancer, but it is already about gene therapy].
Jeanteur P
Bull Cancer; 2000 Jun; 87(6):445-6. PubMed ID: 10928794
[No Abstract] [Full Text] [Related]
10. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
11. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
Egashira M; Ariga T; Kawamura N; Miyoshi O; Niikawa N; Sakiyama Y
Am J Med Genet; 1998 Jan; 75(3):314-7. PubMed ID: 9475605
[TBL] [Abstract][Full Text] [Related]
12. EMA greenlights second gene therapy.
Mullard A
Nat Rev Drug Discov; 2016 May; 15(5):299. PubMed ID: 27139988
[No Abstract] [Full Text] [Related]
13. [Adenosine deaminase deficiency].
Sakiyama Y
Ryoikibetsu Shokogun Shirizu; 2000; (32):32-4. PubMed ID: 11212730
[No Abstract] [Full Text] [Related]
14. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
15. Natural gene therapy and the Darwinian legacy.
Youssoufian H
Nat Genet; 1996 Jul; 13(3):255-6. PubMed ID: 8673116
[No Abstract] [Full Text] [Related]
16. [Adenosine deaminase deficiency].
Okawa H
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):240-2. PubMed ID: 9833480
[No Abstract] [Full Text] [Related]
17. A small step for gene therapy.
Nat Genet; 1994 Apr; 6(4):323-4. PubMed ID: 8054965
[No Abstract] [Full Text] [Related]
18. US panel advises resumption of gene trials.
Fox JL
Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
[No Abstract] [Full Text] [Related]
19. Gene therapy's out-of-body experience.
Scott CT; DeFrancesco L
Nat Biotechnol; 2016 Jun; 34(6):600-7. PubMed ID: 27281416
[No Abstract] [Full Text] [Related]
20. Bubble babies and bathwater.
Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
[No Abstract] [Full Text] [Related]
[Next] [New Search]